Skip to main content
  • Home
  • Our Business
    • Contract Manufacturing Business
    • Mammalian Cell Culture
    • Microbial Technologies
    • cGMP Manufacturing
    • Upstream and Downstream Processing
    • Monoclonal antibody
    • Fab Fragments
    • plasmid DNA
    • Fill & Finish
  • Global Network
    • Biberach, Germany
    • Vienna, Austria
    • Fremont, USA
    • Shanghai, China
  • About Us
    • Boehringer Ingelheim BioXcellence™
    • Our History
    • Our People
    • Our Track Record
    • Our Customers
  • Media & News
    • Whitepaper
    • Press Releases
    • Videos
    • Information Brochures
  • Contact Us
    • Contact Form
    • Upcoming Conferences
  • Home
  • Our Business
  • Global Network
  • About Us
  • Media & News
    • Whitepaper
    • Press Releases
    • Videos
    • Information Brochures
  • Contact Us

Search form

Press Releases Archive Boehringer Ingelheim BioXcellence™
  • Home
  • Our Business
  • Global Network
  • About Us
  • Media & News
    • PR_2017-05-16
    • PR_2017-07-21
    • PR_2018-07-04
    • PR_2018-08-20
    • PR_2018-09-03
    • PR_2018-09-26
    • PR_2018-10-31
    • PR_2019-01-17
    • PR_2019-11-05
    • PR_2019-12-30
    • PR_2020-04-09
    • Press Release Archive
      • PR_2015-08-25
      • PR_2015-12-22
  • Contact Us
  • Search
  • Terms of use
  • Data Privacy
  • Imprint
  • Error

Press Release Archive

22.12.2015

Boehringer Ingelheim Invests in Europe: Pharma Company Expands Biopharmaceutical Production at Vienna Site

25.08.2015

Boehringer Ingelheim China Biopharmaceuticals Site celebrates milestone to bolster Shanghai’s innovation center ambition

  • Print Page
  • Careers
  • Terms of Use
  • Data Privacy
  • Imprint
Print Page

© 2010 - 2020 Boehringer Ingelheim Biopharmaceuticals GmbH. All rights reserved

Boehringer Ingelheim